-
Indices from the Asia-Pacific region post a mixed session. Chinese indices are down between 0.70–1.20%. Australian and Singaporean indices are losing around 0.20%, while the Japanese index is trading flat.
-
Today, market focus is on the U.S. nonfarm payrolls report, which will be published on Thursday instead of Friday due to the July 4th holiday. The report is key following the first negative ADP data since early 2022 on Wednesday.
-
Donald Trump has once again called for Fed Chair Jerome Powell to resign immediately. There is speculation that Trump may have had access to upcoming labor market data, suggesting a weak reading.
-
Powell’s future at the Fed remains uncertain — his term ends in May 2026, but he could stay on the board until 2028.
-
The House of Representatives has yet to vote on the “Big Beautiful Bill” backed by Trump. Speaker Mike Johnson has left the vote open indefinitely as he attempts to secure a majority. The delay highlights internal Republican divisions, and the outcome is crucial for Trump’s broader economic agenda.
-
Bank of Japan board member Hajime Takata expressed support for resuming interest rate hikes, citing strong corporate results and rising wages.
-
Australia posted a trade surplus of AUD 2.24 billion in May, well below the forecast of AUD 5.1 billion. Exports fell 2.7% m/m, while imports rose 3.8%. The data did not trigger a major market reaction.
-
Japan’s final June services PMI rose to 51.7, marking the third straight month of expansion. Business sentiment reached a four-month high, although export growth slowed slightly.
-
South Korean President Lee warned that tariff negotiations with the U.S. are very difficult. He stressed the need for a practical, mutually beneficial approach, but acknowledged that reaching an agreement by July 8 would be challenging.
-
South Korean intelligence reports that North Korea may send up to 30,000 troops to Russia under a military agreement. Deployment could begin as early as July or August.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
